Titulo:
Tratamiento multimodal de carcinoma adrenocortical metastásico: caso clínico y propuesta de estrategia integral en Colombia
.
Guardado en:
2256-2877
2256-2915
11
2024-12-05
93
102
Revista colombiana de hematología y oncología - 2024
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
| id |
metarevistapublica_acho_revistacolombianadehematologiayoncologia_27-article-699 |
|---|---|
| record_format |
ojs |
| institution |
ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA |
| thumbnail |
https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADEHEMATOLOGIAYONCOLOGIA/logo.png |
| country_str |
Colombia |
| collection |
Revista Colombiana de Hematología y Oncología |
| title |
Tratamiento multimodal de carcinoma adrenocortical metastásico: caso clínico y propuesta de estrategia integral en Colombia |
| spellingShingle |
Tratamiento multimodal de carcinoma adrenocortical metastásico: caso clínico y propuesta de estrategia integral en Colombia Pérez Lugo, Lucy Maritza Osorio Franco, Álvaro Enrique adrenocortical carcinoma neoplasias de la corteza suprarrenal cushing syndrome mitotane adrenal glands glándulas suprarrenales mitotane síndrome de Cushing adrenal gland neoplasms carcinoma corticosuprarrenal |
| title_short |
Tratamiento multimodal de carcinoma adrenocortical metastásico: caso clínico y propuesta de estrategia integral en Colombia |
| title_full |
Tratamiento multimodal de carcinoma adrenocortical metastásico: caso clínico y propuesta de estrategia integral en Colombia |
| title_fullStr |
Tratamiento multimodal de carcinoma adrenocortical metastásico: caso clínico y propuesta de estrategia integral en Colombia |
| title_full_unstemmed |
Tratamiento multimodal de carcinoma adrenocortical metastásico: caso clínico y propuesta de estrategia integral en Colombia |
| title_sort |
tratamiento multimodal de carcinoma adrenocortical metastásico: caso clínico y propuesta de estrategia integral en colombia |
| author |
Pérez Lugo, Lucy Maritza Osorio Franco, Álvaro Enrique |
| author_facet |
Pérez Lugo, Lucy Maritza Osorio Franco, Álvaro Enrique |
| topic |
adrenocortical carcinoma neoplasias de la corteza suprarrenal cushing syndrome mitotane adrenal glands glándulas suprarrenales mitotane síndrome de Cushing adrenal gland neoplasms carcinoma corticosuprarrenal |
| topic_facet |
adrenocortical carcinoma neoplasias de la corteza suprarrenal cushing syndrome mitotane adrenal glands glándulas suprarrenales mitotane síndrome de Cushing adrenal gland neoplasms carcinoma corticosuprarrenal |
| citationvolume |
11 |
| citationissue |
2 |
| citationedition |
Núm. 2 , Año 2024 : Julio - Diciembre |
| publisher |
Bogotá: Asociación Colombiana de Hematología y Oncología, 2012- |
| ispartofjournal |
Revista colombiana de hematología y oncología |
| source |
https://revista.acho.info/index.php/acho/article/view/699 |
| language |
|
| format |
Article |
| rights |
Revista colombiana de hematología y oncología - 2024 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0. info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-nd/4.0 |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_6501 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2024-12-05 |
| date_accessioned |
2024-12-05 00:00:00 |
| date_available |
2024-12-05 00:00:00 |
| url |
https://revista.acho.info/index.php/acho/article/view/699 |
| url_doi |
https://doi.org/10.51643/22562915.699 |
| issn |
2256-2877 |
| eissn |
2256-2915 |
| doi |
10.51643/22562915.699 |
| citationstartpage |
93 |
| citationendpage |
102 |
| url2_str_mv |
https://revista.acho.info/index.php/acho/article/download/699/643 |
| _version_ |
1818394545808736256 |
| spelling |
Tratamiento multimodal de carcinoma adrenocortical metastásico: caso clínico y propuesta de estrategia integral en Colombia 11 Pérez Lugo, Lucy Maritza Bogotá: Asociación Colombiana de Hematología y Oncología, 2012- Artículo de revista Núm. 2 , Año 2024 : Julio - Diciembre 2 Revista colombiana de hematología y oncología Osorio Franco, Álvaro Enrique Journal article info:eu-repo/semantics/article Revista colombiana de hematología y oncología - 2024 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0. 93 102 Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A. Extent of Disease at Presentation and Outcome for Adrenocortical Carcinoma: Have We Made Progress? World J Surg [Internet]. 2006;30(5):1658. Disponible en: https://doi.org/10.1007/s00268-005-0329-x 2. Passman JE, Amjad W, Soegaard Ballester JM, Ginzberg SP, Wachtel H. Defining Optimal Management of Non-metastatic Adrenocortical Carcinoma. Ann Surg Oncol [Internet]. 2024;31(2):1097-1107. Disponible en: https://doi.org/10.1245/s10434-023-14533-w 3. Wooten MD, King DK. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer [Internet]. 1993;72(11):3145-3155. Disponible en: https://doi.org/10.1002/1097-0142(19931201)72:11<3145::aid-cncr2820721105>3.0.co;2-n 4. Ayala-Ramirez M, Jasim S, Feng L, et al. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol [Internet]. 2013;169(6):891-899. Disponible en: https://doi.org/10.1530/EJE-13-0519 5. Alexander K, Katherine M, Daniel C, Yu-Ning W, G UR. Effects of Increased Cross-Sectional Imaging on the Diagnosis and Prognosis of Adrenocortical Carcinoma: Analysis of the National Cancer Database. Journal of Urology [Internet]. 2011;186(3):805-810. Disponible en: https://doi.org/10.1016/j.juro.2011.04.072 6. Mihai R. Diagnosis, treatment and outcome of adrenocortical cancer. British Journal of Surgery [Internet]. 2015;102(4):291-306. Disponible en: https://doi.org/10.1002/bjs.9743 7. Libé R, Huillard O. Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease. Cancer Treat Res Commun [Internet]. 2023;37:100759. Disponible en: https://doi.org/https://doi.org/10.1016/j.ctarc.2023.100759 8. Libé R, Borget I, Ronchi CL, et al. Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Annals of Oncology [Internet]. 2015;26(10):2119-2125. Disponible en: https://doi.org/10.1093/annonc/mdv329 9. Ng L, Libertino J. Adrenocortical Carcinoma: Diagnosis, Evaluation and Treatment. J Urol [Internet]. 2003;169:5-11. Disponible en: https://doi.org/10.1097/01.ju.0000030148.59051.35 10. Libé R, Huillard O. Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease. Cancer Treat Res Commun [Internet]. 2023;37:100759. Disponible en: https://doi.org/10.1016/j.ctarc.2023.100759 11. Schteingart DE. Adjuvant Mitotane Therapy of Adrenal Cancer-Use and Controversy. New England Journal of Medicine [Internet]. 2007;356(23):2415-2418. Disponible en: https://doi.org/10.1056/NEJMe078087 12. Koch CA, Pacak K, Chrousos GP. The Molecular Pathogenesis of Hereditary and Sporadic Adrenocortical and Adrenomedullary Tumors. J Clin Endocrinol Metab [Internet]. 2002;87(12):5367-5384. Disponible en: https://doi.org/10.1210/jc.2002-021069 13. Zheng S, Cherniack AD, Dewal N, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell [Internet]. 2016;29(5):723-736. Disponible en: https://doi.org/10.1016/j.ccell.2016.04.002 14. Juhlin CC, Goh G, Healy JM, et al. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma. Journal of Clinical Endocrinology and Metabolism [Internet]. 2015;100(3):E493-E502. Disponible en: https://doi.org/10.1210/JC.2014-3282 15. Assié G, Letouzé E, Fassnacht M, et al. Integrated genomic characterization of adrenocortical carcinoma. Nat Genet [Internet]. 2014;46(6):607-612. Disponible en: https://doi.org/10.1038/ng.2953 16. Abiven G, Coste J, Groussin L, et al. Clinical and Biological Features in the Prognosis of Adrenocortical Cancer: Poor Outcome of Cortisol-Secreting Tumors in a Series of 202 Consecutive Patients. J Clin Endocrinol Metab [Internet]. 2006;91(7):2650-2655. Disponible en: https://doi.org/10.1210/jc.2005-2730 17. Fassnacht M, Dekkers OM, Else T, et al. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol [Internet]. 2018;179(4):G1-G46. Disponible en: https://doi.org/10.1530/EJE-18-0608 18. McCarthy CJ, McDermott S, Blake MA. Adrenal Imaging: Magnetic Resonance Imaging and Computed Tomography. Front Horm Res [Internet]. 2016;45:55-69. Disponible en: https://doi.org/10.1159/000442313 19. Fassnacht M, Assie G, Baudin E, et al. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology [Internet]. 2020;31(11):1476-1490. Disponible en: https://doi.org/10.1016/j.annonc.2020.08.2099 20. Fassnacht M, Johanssen S, Quinkler M, et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma. Cancer [Internet]. 2009;115(2):243-250. Disponible en: https://doi.org/https://doi.org/10.1002/cncr.24030 21. Lughezzani G, Sun M, Perrotte P, et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: A North American validation. Eur J Cancer. [Internet] 2010;46(4):713-719. Disponible en: https://doi.org/10.1016/j.ejca.2009.12.007 22. Stojadinovic A, Ghossein RA, Hoos A, et al. Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization. Journal of Clinical Oncology 2002;20(4):941-950. Disponible en: https://doi.org/10.1200/JCO.2002.20.4.941 23. Vassilopoulou-Sellin R, Schultz P. Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer [Internet]. 2001;92:1113-1121. Disponible en: https://doi.org/10.1002/1097-0142(20010901)92:5<1113::aid-cncr1428>3.0.co;2-i 24. Icard P, Goudet P, Charpenay C, et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg [Internet]. 2001;25(7):891-897. Disponible en: https://doi.org/10.1007/s00268-001-0047-y 25. Schulick RD, Brennan MF. Long-Term Survival After Complete Resection and Repeat Resection in Patients With Adrenocortical Carcinoma. Ann Surg Oncol [Internet]. 1999;6(8):719-726. Disponible en: https://doi.org/10.1007/s10434-999-0719-7 26. Gaujoux S, Mihai R, Carnaille B, et al. European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma. British Journal of Surgery [Internet]. 2017;104(4):358-376. Disponible en: https://doi.org/10.1002/bjs.10414 27. Waszut U, Szyska P, Dworakowska D. Understanding mitotane mode of action. J Physiol Pharmacol. [Internet]. 2017;68:13-26. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28456766/ PMID: 28456766 28. Terzolo M, Zaggia B, Allasino B, De Francia S. Practical treatment using mitotane for adrenocortical carcinoma. Curr Opin Endocrinol Diabetes Obes [Internet]. 2014;21(3). Disponible en: https://journals.lww.com/co-endocrinology/fulltext/2014/06000/practical_treatment_using_mitotane_for.4.aspx 29. Terzolo M, Fassnacht M, Perotti P, et al. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study. Lancet Diabetes Endocrinol [Internet]. 2023;11(10):720-730. Disponible en: https://doi.org/10.1016/S2213-8587(23)00193-6 30. Kimpel O, Bedrose S, Megerle F, et al. Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study. Br J Cancer [Internet]. 2021;125(9):1233-1238. Disponible en: https://doi.org/10.1038/s41416-021-01513-8 31. Else T, Kim AC, Sabolch A, et al. Adrenocortical Carcinoma. Endocr Rev [Internet]. 2014;35(2):282-326. Disponible en: https://doi.org/10.1210/er.2013-1029 32. Polat B, Fassnacht M, Pfreundner L, et al. Radiotherapy in adrenocortical carcinoma. Cancer [Internet]. 2009;115(13):2816-2823. Disponible en: https://doi.org/10.1002/cncr.24331 33. Paragliola RM, Corsello A, Locantore P, Papi G, Pontecorvi A, Corsello SM. Medical Approaches in Adrenocortical Carcinoma. Biomedicines [Internet]. 2020;8(12):1-18. Disponible en: https://doi.org/10.3390/BIOMEDICINES8120551 34. Fassnacht M, Terzolo M, Allolio B, et al. Combination Chemotherapy in Advanced Adrenocortical Carcinoma. New England Journal of Medicine [Internet]. 2012;366(23):2189-2197. Disponible en: https://doi.org/10.1056/NEJMoa1200966 35. Raj N, Zheng Y, Kelly V, et al. PD-1 Blockade in Advanced Adrenocortical Carcinoma. Journal of Clinical Oncology [Internet]. 2019;38(1):71-80. Disponible en: https://doi.org/10.1200/JCO.19.01586 36. Habra MA, Stephen B, Campbell M, et al. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. J Immunother Cancer [Internet]. 2019;7(1):253. Disponible en: https://doi.org/10.1186/s40425-019-0722-x 37. Naing A, Meric-Bernstam F, Stephen B, et al. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer [Internet]. 2020;8(1):e000347. Disponible en: https://doi.org/10.1136/jitc-2019-000347 38. Chukkalore D, MacDougall K, Master V, Bilen MA, Nazha B. Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches. Oncologist [Internet]. February 21, 2024:oyae029. Disponible en: https://doi.org/10.1093/oncolo/oyae029 https://revista.acho.info/index.php/acho/article/download/699/643 adrenocortical carcinoma http://purl.org/coar/resource_type/c_6501 http://purl.org/redcol/resource_type/ARTREF info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text https://creativecommons.org/licenses/by-nc-nd/4.0 10.51643/22562915.699 https://doi.org/10.51643/22562915.699 neoplasias de la corteza suprarrenal cushing syndrome mitotane adrenal glands glándulas suprarrenales mitotane síndrome de Cushing 2024-12-05 00:00:00 adrenal gland neoplasms 2024-12-05 00:00:00 2024-12-05 application/pdf carcinoma corticosuprarrenal 2256-2877 2256-2915 https://revista.acho.info/index.php/acho/article/view/699 Publication |